Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG

By Isolauri E.   Joensuu J.   Suomalainen H.   Luomala M.   Vesikari T.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 310-312

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants

By Clements-Mann M.L.   Dudas R.   Hoshino Y.   Nehring P.   Sperber E.   Wagner M.   Stephens I.   Karron R.   Deforest A.   Kapikian A.Z.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4676-4684

Elsevier

Access to resources Recommend Favorite

Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK

By Hoshino Y.   Jones R.W.   Chanock R.M.   Kapikian A.Z.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3576-3584

Elsevier

Access to resources Recommend Favorite

New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus

By Wood D.J.  

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 341-345

Elsevier

Access to resources Recommend Favorite

Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru

By Lanata C.F.   Black R.E.   Flores J.   Lazo F.   Butron B.   Linares A.   Huapaya A.   Ventura G.   Gil A.   Kapikian A.Z.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 237-243

Elsevier

Access to resources Recommend Favorite